Published in Cell Tissue Res on August 21, 2007
Neural regeneration and cell replacement: a view from the eye. Cell Stem Cell (2008) 1.61
Forcing stem cells to behave: a biophysical perspective of the cellular microenvironment. Annu Rev Biophys (2012) 1.55
Resistance of glioblastoma-initiating cells to radiation mediated by the tumor microenvironment can be abolished by inhibiting transforming growth factor-β. Cancer Res (2012) 1.34
Müller glia: Stem cells for generation and regeneration of retinal neurons in teleost fish. Prog Retin Eye Res (2014) 1.30
Therapeutic targets in malignant glioblastoma microenvironment. Semin Radiat Oncol (2009) 1.11
The neuroprotective functions of transforming growth factor beta proteins. Int J Mol Sci (2012) 1.06
Dynamic changes in Ezh2 gene occupancy underlie its involvement in neural stem cell self-renewal and differentiation towards oligodendrocytes. PLoS One (2012) 0.96
Retinal regeneration in adult zebrafish requires regulation of TGFβ signaling. Glia (2013) 0.95
TGF-beta signalling in the adult neurogenic niche promotes stem cell quiescence as well as generation of new neurons. J Cell Mol Med (2014) 0.95
Transforming Growth Factor-Beta Signaling in the Neural Stem Cell Niche: A Therapeutic Target for Huntington's Disease. Neurol Res Int (2011) 0.92
Interleukin-1β and transforming growth factor-β cooperate to induce neurosphere formation and increase tumorigenicity of adherent LN-229 glioma cells. Stem Cell Res Ther (2012) 0.92
Co-evolution of breast-to-brain metastasis and neural progenitor cells. Clin Exp Metastasis (2013) 0.91
Smad7 regulates the adult neural stem/progenitor cell pool in a transforming growth factor beta- and bone morphogenetic protein-independent manner. Mol Cell Biol (2010) 0.91
Lessons from the embryonic neural stem cell niche for neural lineage differentiation of pluripotent stem cells. Stem Cell Rev (2012) 0.90
Human stem/progenitor cells from bone marrow enhance glial differentiation of rat neural stem cells: a role for transforming growth factor β and Notch signaling. Stem Cells Dev (2010) 0.90
Cytokine networks in glioma. Neurosurg Rev (2011) 0.88
Tregs and infections: on the potential value of modifying their function. J Leukoc Biol (2011) 0.88
Expression profile of differentiating serotonin neurons derived from rhesus embryonic stem cells and comparison to adult serotonin neurons. Gene Expr Patterns (2008) 0.86
Radiation-induced glioblastoma signaling cascade regulates viability, apoptosis and differentiation of neural stem cells (NSC). Apoptosis (2014) 0.82
TGFβ Contributes to the Anti-inflammatory Effects of Tauroursodeoxycholic Acid on an Animal Model of Acute Neuroinflammation. Mol Neurobiol (2016) 0.80
Effect of NDP-α-MSH on PPAR-γ and -β expression and anti-inflammatory cytokine release in rat astrocytes and microglia. PLoS One (2013) 0.79
Inflammation and Gliomagenesis: Bi-Directional Communication at Early and Late Stages of Tumor Progression. Curr Pathobiol Rep (2013) 0.79
Impaired TGF-β induced growth inhibition contributes to the increased proliferation rate of neural stem cells harboring mutant p53. Am J Cancer Res (2015) 0.78
Anterograde Activin signaling regulates postsynaptic membrane potential and GluRIIA/B abundance at the Drosophila neuromuscular junction. PLoS One (2014) 0.78
Essential gene pathways for glioblastoma stem cells: clinical implications for prevention of tumor recurrence. Cancers (Basel) (2011) 0.78
Reduction in subventricular zone-derived olfactory bulb neurogenesis in a rat model of Huntington's disease is accompanied by striatal invasion of neuroblasts. PLoS One (2015) 0.77
Transcriptomic Analysis of Purified Embryonic Neural Stem Cells from Zebrafish Embryos Reveals Signaling Pathways Involved in Glycine-Dependent Neurogenesis. Front Mol Neurosci (2016) 0.77
TGFβ-Responsive HMOX1 Expression Is Associated with Stemness and Invasion in Glioblastoma Multiforme. Stem Cells (2016) 0.76
Protective Effect of Antioxidants on Neuronal Dysfunction and Plasticity in Huntington's Disease. Oxid Med Cell Longev (2017) 0.75
A Cell-Surface Membrane Protein Signature for Glioblastoma. Cell Syst (2017) 0.75
BMP- and TGFβ-signaling regulate the formation of Müller glia-derived progenitor cells in the avian retina. Glia (2017) 0.75
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med (2005) 74.55
Neuroplasticity: changes in grey matter induced by training. Nature (2004) 7.35
CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res (2007) 6.21
Doublecortin expression levels in adult brain reflect neurogenesis. Eur J Neurosci (2005) 3.79
Temozolomide preferentially depletes cancer stem cells in glioblastoma. Cancer Res (2008) 2.84
Effects of the implementation of a telemedical stroke network: the Telemedic Pilot Project for Integrative Stroke Care (TEMPiS) in Bavaria, Germany. Lancet Neurol (2006) 2.38
Transcriptional profiles of CD133+ and CD133- glioblastoma-derived cancer stem cell lines suggest different cells of origin. Cancer Res (2010) 1.76
CD133 expression and cancer stem cells predict prognosis in high-grade oligodendroglial tumors. Brain Pathol (2008) 1.56
Preoperative evaluation of carotid artery stenosis: comparison of contrast-enhanced MR angiography and duplex sonography with digital subtraction angiography. AJNR Am J Neuroradiol (2003) 1.46
Transforming growth factor-beta1 is a negative modulator of adult neurogenesis. J Neuropathol Exp Neurol (2006) 1.44
Intracranial hemorrhage: frequency, location, and risk factors identified in a TeleStroke network. Neuroreport (2015) 1.42
Inhibition of TGF-beta2 with AP 12009 in recurrent malignant gliomas: from preclinical to phase I/II studies. Oligonucleotides (2007) 1.40
In vivo optical imaging of neurogenesis: watching new neurons in the intact brain. Mol Imaging (2008) 1.34
Long-term effects of specialized stroke care with telemedicine support in community hospitals on behalf of the Telemedical Project for Integrative Stroke Care (TEMPiS). Stroke (2008) 1.33
The promotion of oriented axonal regrowth in the injured spinal cord by alginate-based anisotropic capillary hydrogels. Biomaterials (2006) 1.30
Lactate promotes glioma migration by TGF-beta2-dependent regulation of matrix metalloproteinase-2. Neuro Oncol (2008) 1.27
Targeted transgene expression in neuronal precursors: watching young neurons in the old brain. Eur J Neurosci (2006) 1.26
Rechallenge with temozolomide in patients with recurrent gliomas. J Neurol (2009) 1.24
Cerebral ischemia-reperfusion injury in rats--a 3 T MRI study on biphasic blood-brain barrier opening and the dynamics of edema formation. J Cereb Blood Flow Metab (2009) 1.23
Striatal deafferentation increases dopaminergic neurogenesis in the adult olfactory bulb. Exp Neurol (2005) 1.22
Mutant alpha-synuclein exacerbates age-related decrease of neurogenesis. Neurobiol Aging (2007) 1.22
Pegylated liposomal doxorubicin-efficacy in patients with recurrent high-grade glioma. Cancer (2004) 1.19
Targeted tumor therapy with the TGF-beta 2 antisense compound AP 12009. Cytokine Growth Factor Rev (2005) 1.19
Mesenchymal stem cells instruct oligodendrogenic fate decision on adult neural stem cells. Stem Cells (2006) 1.14
Can telemedicine contribute to fulfill WHO Helsingborg Declaration of specialized stroke care? Cerebrovasc Dis (2005) 1.11
Salvage therapy in patients with glioblastoma: is there any benefit? Cancer (2003) 1.11
Amyloid-β contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy. Stroke (2011) 1.09
A randomized, double blind, placebo-controlled trial of pioglitazone in combination with riluzole in amyotrophic lateral sclerosis. PLoS One (2012) 1.09
Long-term course and mutational spectrum of spatacsin-linked spastic paraplegia. Ann Neurol (2007) 1.08
Letter by Schlachetzki et al regarding article, "endovascular stroke therapy: tirofiban is associated with risk of fatal intracerebral hemorrhage and poor outcome". Stroke (2013) 1.07
Human in vitro reporter model of neuronal development and early differentiation processes. BMC Neurosci (2008) 1.03
Neuronal precursor-specific activity of a human doublecortin regulatory sequence. J Neurochem (2005) 1.02
Physical activity fails to rescue hippocampal neurogenesis deficits in the R6/2 mouse model of Huntington's disease. Brain Res (2007) 1.02
Stem cell quiescence in the hippocampal neurogenic niche is associated with elevated transforming growth factor-beta signaling in an animal model of Huntington disease. J Neuropathol Exp Neurol (2010) 1.02
Noninvasive in vivo assessment of muscle impairment in the mdx mouse model--a comparison of two common wire hanging methods with two different results. J Neurosci Methods (2011) 1.00
Dopaminergic lesion enhances growth factor-induced striatal neuroblast migration. J Neuropathol Exp Neurol (2008) 1.00
Transcranial ultrasound from diagnosis to early stroke treatment: part 2: prehospital neurosonography in patients with acute stroke: the Regensburg stroke mobile project. Cerebrovasc Dis (2012) 0.98
Observation on the integrity of the blood-brain barrier after microbubble destruction by diagnostic transcranial color-coded sonography. J Ultrasound Med (2002) 0.98
TGF-β2 signaling in high-grade gliomas. Curr Pharm Biotechnol (2011) 0.96
A lightning strike to the head causing a visual cortex defect with simple and complex visual hallucinations. J Neurol Neurosurg Psychiatry (2007) 0.96
Novel POMGnT1 mutations define broader phenotypic spectrum of muscle-eye-brain disease. Neurogenetics (2007) 0.96
The cancer stem cell subtype determines immune infiltration of glioblastoma. Stem Cells Dev (2012) 0.95
TGF-beta signalling in the adult neurogenic niche promotes stem cell quiescence as well as generation of new neurons. J Cell Mol Med (2014) 0.95
Adult retinal pigment epithelium cells express neural progenitor properties and the neuronal precursor protein doublecortin. Brain Res (2005) 0.94
Predictors of survival after severe dysphagic stroke. J Neurol (2005) 0.94
Transforming Growth Factor-Beta Signaling in the Neural Stem Cell Niche: A Therapeutic Target for Huntington's Disease. Neurol Res Int (2011) 0.92
Depressive symptoms and quality of life after thrombolysis in stroke: the TEMPiS study. J Neurol (2010) 0.92
Lactate-modulated induction of THBS-1 activates transforming growth factor (TGF)-beta2 and migration of glioma cells in vitro. PLoS One (2013) 0.91
Smad7 in T cells drives T helper 1 responses in multiple sclerosis and experimental autoimmune encephalomyelitis. Brain (2010) 0.91
Smad7 regulates the adult neural stem/progenitor cell pool in a transforming growth factor beta- and bone morphogenetic protein-independent manner. Mol Cell Biol (2010) 0.91
Comprehensive small animal imaging strategies on a clinical 3 T dedicated head MR-scanner; adapted methods and sequence protocols in CNS pathologies. PLoS One (2011) 0.91
Intracerebral and intrathecal infusion of the TGF-beta 2-specific antisense phosphorothioate oligonucleotide AP 12009 in rabbits and primates: toxicology and safety. Oligonucleotides (2005) 0.90
Recurrent cardiac arrest caused by lateral medulla oblongata infarction. BMJ Case Rep (2009) 0.90
Thrombolysis for stroke in the elderly. J Thromb Thrombolysis (2005) 0.88
A nuclear magnetic resonance biomarker for neural progenitor cells: is it all neurogenesis? Stem Cells (2009) 0.88
Oligodendrogenesis of adult neural progenitors: differential effects of ciliary neurotrophic factor and mesenchymal stem cell derived factors. J Neurochem (2008) 0.88
Transcranial electro-hyperthermia combined with alkylating chemotherapy in patients with relapsed high-grade gliomas: phase I clinical results. J Neurooncol (2009) 0.87
RNOP-09: pegylated liposomal doxorubicine and prolonged temozolomide in addition to radiotherapy in newly diagnosed glioblastoma--a phase II study. BMC Cancer (2009) 0.87
Autologous adult rodent neural progenitor cell transplantation represents a feasible strategy to promote structural repair in the chronically injured spinal cord. Regen Med (2006) 0.86
Temozolomide and 13-cis retinoic acid in patients with anaplastic gliomas: a prospective single-arm monocentric phase-II study (RNOP-05). J Neurooncol (2011) 0.85
The role of ECA transection in the development of masticatory lesions in the MCAO filament model. Exp Neurol (2005) 0.85
Maintenance therapy with 13-cis retinoid acid in high-grade glioma at complete response after first-line multimodal therapy--a phase-II study. J Neurooncol (2004) 0.85
The relationship between plasma D-dimer concentrations and acute ischemic stroke subtypes. J Stroke Cerebrovasc Dis (2007) 0.85
Neurovascular protection by targeting early blood-brain barrier disruption with neurotrophic factors after ischemia-reperfusion in rats*. J Cereb Blood Flow Metab (2013) 0.85
Early changes on electroencephalography in natalizumab-associated progressive multifocal leucoencephalopathy. Mult Scler (2010) 0.85
Fischer-344 rats are unsuitable for the MCAO filament model due to their cerebrovascular anatomy. J Neurosci Methods (2006) 0.84
Long-term outcome after hemicraniectomy for space occupying right hemispheric MCA infarction. Clin Neurol Neurosurg (2005) 0.84
Tenascin-C protein is induced by transforming growth factor-beta1 but does not correlate with time to tumor progression in high-grade gliomas. J Neurooncol (2005) 0.84
Mobilisation of hematopoietic CD34+ precursor cells in patients with acute stroke is safe--results of an open-labeled non randomized phase I/II trial. PLoS One (2011) 0.83
Inhibition of Smad7, a negative regulator of TGF-beta signaling, suppresses autoimmune encephalomyelitis. J Neuroimmunol (2007) 0.83
Effective silencing of EGFR with RNAi demonstrates non-EGFR dependent proliferation of glioma cells. Int J Oncol (2006) 0.83
Complete response after treatment with a somatostatin analogue in an adult patient with recurrent medulloblastoma. Acta Oncol (2007) 0.83
Procarbazine--a traditional drug in the treatment of malignant gliomas. Curr Med Chem (2008) 0.83
Transcranial ultrasound from diagnosis to early stroke treatment. 1. Feasibility of prehospital cerebrovascular assessment. Cerebrovasc Dis (2008) 0.82
Inhibition of immunosuppressive effects of melanoma-inhibiting activity (MIA) by antisense techniques. Int J Cancer (2005) 0.82
Treatment of malignant gliomas with TGF-beta2 antisense oligonucleotides. Expert Rev Anticancer Ther (2009) 0.82
1H-nuclear magnetic resonance spectroscopy of glioblastoma cancer stem cells. Stem Cells Dev (2011) 0.82
Stem cell metabolic and spectroscopic profiling. Trends Biotechnol (2013) 0.82
Melanoma-inhibiting activity (MIA/CD-RAP) is expressed in a variety of malignant tumors of mainly neuroectodermal origin. Anticancer Res (2002) 0.81
Thin corpus callosum and amyotrophy in spastic paraplegia--case report and review of literature. Clin Neurol Neurosurg (2005) 0.81
Experimental autoimmune encephalomyelitis in the rat spinal cord: lesion detection with high-resolution MR microscopy at 17.6 T. AJNR Am J Neuroradiol (2005) 0.81
Diclofenac inhibits lactate formation and efficiently counteracts local immune suppression in a murine glioma model. Int J Cancer (2012) 0.81
Altered activation patterns within the olfactory network in Parkinson's disease. Cereb Cortex (2010) 0.81
Pegylated liposomal doxorubicin in recurrent malignant glioma: analysis of a case series. Oncology (2008) 0.81
Transcranial ultrasound brain perfusion assessment with a contrast agent-specific imaging mode: results of a two-center trial. Stroke (2005) 0.81
Vascular neurotoxicity following chemotherapy with cisplatin, ifosfamide, and etoposide. Ann Pharmacother (2003) 0.80
Transforming growth factor-β1 primes proliferating adult neural progenitor cells to electrophysiological functionality. Glia (2013) 0.80
Low endogenous recanalization in embolic central retinal artery occlusion--the retrobulbar "spot sign". J Neuroimaging (2014) 0.80
Detection of cardiac right-to-left shunts by contrast-enhanced harmonic carotid duplex sonography. J Ultrasound Med (2005) 0.80
Toll-like receptor triggered dendritic cell maturation and IL-12 secretion are necessary to overcome T-cell inhibition by glioma-associated TGF-beta2. J Neurooncol (2006) 0.80
Increasing capillary diameter and the incorporation of gelatin enhance axon outgrowth in alginate-based anisotropic hydrogels. Acta Biomater (2011) 0.80
Mesenchymal stem cells promote oligodendroglial differentiation in hippocampal slice cultures. Cell Physiol Biochem (2009) 0.80
Expression levels of melanoma inhibitory activity correlate with time to progression in patients with high-grade glioma. Oncol Rep (2004) 0.79
[Spinal and cerebral leptomeningeal seeding from a melanocytoma of the cerebello-pontine angle]. Wien Med Wochenschr (2005) 0.79
In vivo high-resolution imaging of the injured rat spinal cord using a 3.0T clinical MR scanner. J Magn Reson Imaging (2009) 0.79
Bilateral vertebral artery occlusion with retrograde basilary flow in three cases of giant cell arteritis. BMJ Case Rep (2009) 0.79
Adverse effects of the intraluminal filament model of middle cerebral artery occlusion. Stroke (2005) 0.78
Neuroimaging in subclavian steal syndrome. BMJ Case Rep (2009) 0.78
CD95/Fas mediates cognitive improvement after traumatic brain injury. Cell Res (2007) 0.78
Failure of Schwann cells as supporting cells for adult neural progenitor cell grafts in the acutely injured spinal cord. Cell Tissue Res (2006) 0.78